﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Nickan Research Institute</PublisherName>
      <JournalTitle>Immunopathologia Persa</JournalTitle>
      <Issn>2423-8015</Issn>
      <Volume>4</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2018</Year>
        <Month>01</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Histological and immunohistochemically profiles of renal cell carcinoma in northern Nigeria</ArticleTitle>
    <FirstPage>e12</FirstPage>
    <LastPage>
    </LastPage>
    <ELocationID EIdType="doi">10.15171/ipp.2018.12</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Atanda</FirstName>
        <LastName>T. Akinfenwa</LastName>
      </Author>
      <Author>
        <FirstName>Atanda</FirstName>
        <LastName>O. Jareenat</LastName>
      </Author>
      <Author>
        <FirstName>David</FirstName>
        <LastName>T. Noah</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.15171/ipp.2018.12</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>10</Month>
        <Day>18</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>09</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Histologically, renal cell carcinoma (RCC) is classified into predominantly clear cell carcinoma, papillary carcinoma (PC), chromophobe carcinoma, collecting ducts of Bellini carcinoma and Xp11 carcinoma. Objectives: This study aims to evaluate histological profile and staining patterns of RCC subtypes. Materials and Method: All cases of RCC histologically diagnosed in the pathology department of a teaching hospital in northern Nigeria in 2015 were stained using a panel of 34ẞE12, CK7, RCC-ma and CD10 antibodies. Results: Around 23 cases of RCC, at stage III, were diagnosed. Male: Female ratio was 1:1.9 with a mean age of 40±13 years. The tumors comprised of 11 (47.8%), cases of clear cell (CC) carcinoma, 7 (30.4%) cases of PC, 4 (17.4%) cases of chromophobe carcinoma and a case (4.4%) of Xp11.2associated carcinoma. Eighty-eight percent of the CC carcinomas were RCC-ma+, 63% were CD10+ while 50% were CK7+. Seventy-five percent of the PCs were RCC-ma+ and 50% were CD10+. The chromophobe (CP) and the Xp11.2-associated carcinomas were only positive for RCC-ma and CD10. All cases of PCs, chromophobe and Xp11.2 related carcinomas were negative for CK7, and all were 34ẞE12 negative. Conclusion: In contrast to populations with high incidence of RCC, our patients are predominantly female, younger, presented at higher stages and mostly presented with CC carcinoma. </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Renal cell carcinoma</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Clear cell carcinoma</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Chromophobe carcinoma</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Papillary carcinoma</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>